ELITE.E — Elite Naturel Organik Gida Sanayi ve Ticaret AS Balance Sheet
0.000.00%
- TRY4.08bn
- TRY4.01bn
- TRY1.76bn
Annual balance sheet for Elite Naturel Organik Gida Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | Interim Report | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 49.9 | 94.2 | 33.5 | 46.4 | 89.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 104 | 185 | 378 | 576 | 696 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 239 | 370 | 750 | 1,144 | 1,277 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 57.9 | 63.7 | 374 | 605 | 704 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 300 | 435 | 1,136 | 1,774 | 2,008 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 119 | 180 | 272 | 522 | 409 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 168 | 198 | 354 | 607 | 465 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 133 | 236 | 782 | 1,167 | 1,543 |
| Total Liabilities & Shareholders' Equity | 300 | 435 | 1,136 | 1,774 | 2,008 |
| Total Common Shares Outstanding |